BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38186584)

  • 1. Serum Activin A Is a Novel Biomarker of Endoscopic Activity in Ulcerative Colitis.
    Ogihara R; Kurumi H; Kanda T; Yashima K; Isomoto H; Yamaguchi N
    Gastroenterology Res; 2023 Dec; 16(6):334-341. PubMed ID: 38186584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center.
    Suttichaimongkol T; Coelho-Prabhu N; Bruining DH; Tariq R; Snyder MR; Loftus EV
    Inflamm Bowel Dis; 2024 Feb; ():. PubMed ID: 38309716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis.
    Liu XY; Tian ZB; Zhang LJ; Liu AL; Zhang XF; Wu J; Ding XL
    World J Gastroenterol; 2023 Dec; 29(48):6208-6221. PubMed ID: 38186862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common laboratory blood test immune panel markers are useful for grading ulcerative colitis endoscopic severity.
    Cui J; Li X; Zhang Z; Gao H; Li J
    BMC Gastroenterol; 2022 Dec; 22(1):540. PubMed ID: 36572872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission.
    Ishida N; Ito T; Takahashi K; Asai Y; Miyazu T; Higuchi T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Sugimoto K
    World J Gastroenterol; 2023 Dec; 29(47):6111-6121. PubMed ID: 38186681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
    Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Shimodaira Y; Watanabe K; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Scand J Gastroenterol; 2022 Feb; 57(2):165-168. PubMed ID: 34663142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Utility of Leucine-Rich Alpha-2-Glycoprotein as a Biomarker in Ulcerative Colitis: A Predictor of Endoscopic Remission Independent of Symptoms.
    Hayashi T; Kitamura K; Usami M; Miyazawa M; Nishitani M; Dejima A; Yamamoto M; Kawase S; Funaki M; Orita N; Nakagawa H; Morita K; Iida N; Seki A; Nio K; Kido H; Takayama H; Takeuchi Y; Yamada S; Takatori H; Shimada M; Saito H; Yamamoto D; Toyama T; Yamashita T
    Inflamm Intest Dis; 2023 Dec; 8(4):133-142. PubMed ID: 38115911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis.
    Yamazato M; Yanai S; Oizumi T; Eizuka M; Yamada S; Toya Y; Uesugi N; Sugai T; Matsumoto T
    World J Clin Cases; 2023 Nov; 11(32):7753-7760. PubMed ID: 38073694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis.
    Scarallo L; Fioretti L; Paci M; Naldini S; Renzo S; Barp J; Gissi A; Di Paola M; Villanacci V; Lionetti P
    Dig Liver Dis; 2024 Jan; 56(1):43-49. PubMed ID: 37455156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium- to long-term prognosis in patients with active ulcerative colitis.
    Chen L; Yang J; Fang L; Wu W; Feng B; Shi Y; Sun M; Sun X; Liu Z
    Therap Adv Gastroenterol; 2020; 13():1756284820981210. PubMed ID: 33425012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis.
    Uchihara M; Kato J; Tsuda S; Yoshida T; Maekita T; Iguchi M; Kitano M
    JGH Open; 2017 Nov; 1(3):98-104. PubMed ID: 30483544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis.
    Sakuraba A; Nemoto N; Hibi N; Ozaki R; Tokunaga S; Kikuchi O; Minowa S; Mitsui T; Miura M; Saito D; Hayashida M; Miyoshi J; Matsuura M; Yoneyama M; Ohnishi H; Hisamatsu T
    BMC Gastroenterol; 2021 May; 21(1):197. PubMed ID: 33933033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
    Shin J; Kong SM; Seong G; Kim YH
    Int J Colorectal Dis; 2020 Dec; 35(12):2249-2255. PubMed ID: 32749515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study.
    Shah J; Dutta U; Das A; Sharma V; Mandavdhare H; Sharma P; Kalsi D; Popli P; Kochhar R
    JGH Open; 2020 Jun; 4(3):382-386. PubMed ID: 32514441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.